Literature DB >> 20189268

[Recomendations for the prevention of adverse drug reactions in older adults with dementia].

Javier Gómez-Pavón1, Paloma González García, Inés Francés Román, Maite Vidán Astiz, José Gutiérrez Rodríguez, Gregorio Jiménez Díaz, Nuria Pilar Montero Fernández, Baldomero Alvarez Fernández, José María Jiménez Páez.   

Abstract

The elderly are one of the groups at greatest risk for adverse drugs reactions (ADR). The mean prevalence of these reactions in this population is 30%. Dementia is not an independent risk factor of ADR, but is the main condition that increases all risk factors (polypharmacy, comorbidity, inappropriate prescribing, drug-drug interactions, advanced age, and treatment adherence). The present article discusses revised and consensual recommendations for the prevention of ADR in the elderly, as well as recommendations specifically for dementia patients in relation to the management of comorbidity and cognitive, behavioral and psychological symptoms. Copyright 2009 SEGG. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20189268     DOI： 10.1016/j.regg.2009.10.002

Source DB:  PubMed          Journal:  Rev Esp Geriatr Gerontol        ISSN： 0211-139X


  7 in total

1.  Optimising primary care for people with dementia.

Authors:  Chris Fox; Ian Maidment; Esme Moniz-Cook; Jacquie White; Jochen René Thyrian; John Young; Cornelius Katona; Carolyn A Chew-Graham
Journal:  Ment Health Fam Med       Date:  2013-09

2.  Cost-utility analysis of a consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients.

Authors:  Mireia Massot Mesquida; Frans Folkvord; Gemma Seda; Francisco Lupiáñez-Villanueva; Pere Torán Monserrat
Journal:  BMC Geriatr       Date:  2021-05-22       Impact factor: 3.921

3.  Perspectives of carers on medication management in dementia: lessons from collaboratively developing a research proposal.

Authors:  Fiona Poland; Sarah Mapes; Hilary Pinnock; Cornelius Katona; Susanne Sorensen; Chris Fox; Ian D Maidment
Journal:  BMC Res Notes       Date:  2014-07-21

4.  A qualitative study exploring medication management in people with dementia living in the community and the potential role of the community pharmacist.

Authors:  Ian D Maidment; Lydia Aston; Tiago Moutela; Chris G Fox; Andrea Hilton
Journal:  Health Expect       Date:  2017-01-19       Impact factor: 3.377

5.  Consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients.

Authors:  Mireia Massot Mesquida; Montserrat Tristany Casas; Alicia Franzi Sisó; Isabel García Muñoz; Óscar Hernández Vian; Pere Torán Monserrat
Journal:  BMC Geriatr       Date:  2019-01-08       Impact factor: 3.921

6.  [Adverse reactions to drugs used for COVID-19 in five Latin American countriesReações adversas a medicamentos utilizados para a COVID-19 em cinco países da América Latina].

Authors:  Tatiana Orjuela-Rodríguez; Robin Rojas-Cortés; Verónica Vergara; Francisca Aldunate; Giset Jiménez; Ismary Alfonso Orta; Kelly Serrano; Giovanna Jiménez; Diana Marcela Gil González; Diego Gutiérrez; Francisco Bosco Cortez; José David González; Analía Porrás; José Luis Castro
Journal:  Rev Panam Salud Publica       Date:  2022-09-30

7.  Improving the management of behaviour that challenges associated with dementia in care homes: protocol for pharmacy-health psychology intervention feasibility study.

Authors:  Ian D Maidment; Rachel L Shaw; Kirsty Killick; Sarah Damery; Andrea Hilton; Jane Wilcock; Nigel Barnes; Graeme Brown; Sarah Gillespie; Chris Fox; Garry Barton; Steve Iliffe; Nichola Seare
Journal:  BMJ Open       Date:  2016-03-23       Impact factor: 2.692
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.